**Molecular Mechanism and Rationale**
The complement system's classical pathway, initiated by C1q complex formation, represents a critical convergence point between innate immunity and synaptic plasticity in the central nervous system. The C1q complex consists of three distinct subunits—C1QA, C1QB, and C1QC—that form a hexameric structure (A₂B₂C₂) essential for complement activation. In Alzheimer's disease pathophysiology, aberrant complement activation drives circuit-specific synaptic eliminat
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.72
Evidence
0.68
Novelty
0.58
Feasibility
0.45
Impact
0.65
Druggability
0.48
Safety
0.38
Competition
0.52
Data
0.55
Reproducible
0.60
KG Connect
0.22
Score Breakdown
Dimension
C1QA/C1QB Subunit-Specific Inh
Mechanistic
0.720
Evidence
0.680
Novelty
0.580
Feasibility
0.450
Impact
0.650
Druggability
0.480
Safety
0.380
Competition
0.520
Data
0.550
Reproducible
0.600
KG Connect
0.216
Evidence
C1QA/C1QB Subunit-Specific Inhibition to Block Aberrant PV I
No evidence citations yet
Debate Excerpts
C1QA/C1QB Subunit-Specific Inhibition to Block Abe
# Critical Evaluation of SST/PV Interneuron Dysfunction Hypotheses
## Framing the Debate
The core issue is distinguishing between two causal models:
- **Model A (Compensation)**: Amyloid impairs e...
Persona-Domain Expert
# Domain Expert Assessment: SST/PV Interneuron Dysfunction in Alzheimer's Disease
## Question 1: Highest Translational Potential Hypotheses
Based on the current Alzheimer's therapeutic landscape—d...